Lv61
2690 积分 2021-04-11 加入
Safety and efficacy of GLP-1/FGF21 dual agonist HEC88473 in MASLD and T2DM: A randomized, double-blind, placebo-controlled study
1小时前
已完结
Effects of empagliflozin on liver fat in patients with metabolic dysfunction–associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial
1小时前
已完结
Meta-analysis of α-blockade versus no blockade before adrenalectomy for phaeochromocytoma
4个月前
已完结
Prevalence of obesity and associated complications in China: A cross‐sectional, real‐world study in 15.8 million adults
7个月前
已完结
The Kidney in Obesity: Current Evidence, Perspectives and Controversies
7个月前
已完结
Obesity and the kidney: mechanistic links and therapeutic advances
7个月前
已完结
Obesity and Dyslipidemia: A Review of Current Evidence
7个月前
已完结
American Association of Clinical Endocrinology Consensus Statement: Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Based Chronic Disease – 2025 Update
7个月前
已完结
Atherosclerotic Cardiovascular Disease or Heart Failure: First Cardiovascular Event in Adults With Prediabetes and Diabetes
7个月前
已完结
皖公网安备34019202002308
